The use of stroke volume variation to guide donor management is associated with increased organs transplanted per donor

Benjamin Bergstrom, J. Salvador De La Cruz, Mitchell Sally, Scott Louis, Melissa Friedman, Floyd Petersen, Darren Malinoski

Research output: Contribution to journalArticle

Abstract

Background: There is a national shortage of organs available for transplantation, and utilization rates for thoracic organs are less than 40%. In addition, the optimal method of assessing cardiovascular status during donor management is uncertain. FloTrac is a noninvasive hemodynamic technique that measures cardiac output and fluid responsiveness. Our objective was to measure the impact of using this technique to guide management on fluid balance, vasopressor usage, thyroid hormone usage, and pulmonary function. We hypothesized that FloTrac guidance will increase thoracic organs transplanted per donor (OTPD). Methods: Data were prospectively collected on a convenience sample of 38 donors after neurologic determination of death. Organs transplanted, net fluid balance, dosage of vasopressors, dosage of thyroid hormone, and PaO2:FIO2 were compared between treatment and control groups. Results: The treatment group had greater thoracic OTPD (1.3 [1.0] vs 0.4 [0.6], P = .004) and overall OTPD (4.3 [1.5] vs 2.7 [1.5], P = .002). Donors in the treatment group maintained a neutral fluid balance, had more thyroid hormone used, and had an improvement in oxygenation. Conclusion: The implementation of this technology to aid providers may help ameliorate the shortage of thoracic and overall organs available for transplantation.

Original languageEnglish (US)
Pages (from-to)200-206
Number of pages7
JournalProgress in Transplantation
Volume27
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Stroke Volume
Water-Electrolyte Balance
Thorax
Thyroid Hormones
Organ Transplantation
Cardiac Output
Nervous System
Hemodynamics
Technology
Lung
Control Groups

Keywords

  • Donor management
  • Stroke volume variation
  • Transplantation

ASJC Scopus subject areas

  • Medicine(all)
  • Transplantation

Cite this

The use of stroke volume variation to guide donor management is associated with increased organs transplanted per donor. / Bergstrom, Benjamin; De La Cruz, J. Salvador; Sally, Mitchell; Louis, Scott; Friedman, Melissa; Petersen, Floyd; Malinoski, Darren.

In: Progress in Transplantation, Vol. 27, No. 2, 2017, p. 200-206.

Research output: Contribution to journalArticle

Bergstrom, Benjamin ; De La Cruz, J. Salvador ; Sally, Mitchell ; Louis, Scott ; Friedman, Melissa ; Petersen, Floyd ; Malinoski, Darren. / The use of stroke volume variation to guide donor management is associated with increased organs transplanted per donor. In: Progress in Transplantation. 2017 ; Vol. 27, No. 2. pp. 200-206.
@article{198c952acf37421c90c80cad321c8f74,
title = "The use of stroke volume variation to guide donor management is associated with increased organs transplanted per donor",
abstract = "Background: There is a national shortage of organs available for transplantation, and utilization rates for thoracic organs are less than 40{\%}. In addition, the optimal method of assessing cardiovascular status during donor management is uncertain. FloTrac is a noninvasive hemodynamic technique that measures cardiac output and fluid responsiveness. Our objective was to measure the impact of using this technique to guide management on fluid balance, vasopressor usage, thyroid hormone usage, and pulmonary function. We hypothesized that FloTrac guidance will increase thoracic organs transplanted per donor (OTPD). Methods: Data were prospectively collected on a convenience sample of 38 donors after neurologic determination of death. Organs transplanted, net fluid balance, dosage of vasopressors, dosage of thyroid hormone, and PaO2:FIO2 were compared between treatment and control groups. Results: The treatment group had greater thoracic OTPD (1.3 [1.0] vs 0.4 [0.6], P = .004) and overall OTPD (4.3 [1.5] vs 2.7 [1.5], P = .002). Donors in the treatment group maintained a neutral fluid balance, had more thyroid hormone used, and had an improvement in oxygenation. Conclusion: The implementation of this technology to aid providers may help ameliorate the shortage of thoracic and overall organs available for transplantation.",
keywords = "Donor management, Stroke volume variation, Transplantation",
author = "Benjamin Bergstrom and {De La Cruz}, {J. Salvador} and Mitchell Sally and Scott Louis and Melissa Friedman and Floyd Petersen and Darren Malinoski",
year = "2017",
doi = "10.1177/1526924817699966",
language = "English (US)",
volume = "27",
pages = "200--206",
journal = "Progress in Transplantation",
issn = "1526-9248",
publisher = "InnoVision Communications",
number = "2",

}

TY - JOUR

T1 - The use of stroke volume variation to guide donor management is associated with increased organs transplanted per donor

AU - Bergstrom, Benjamin

AU - De La Cruz, J. Salvador

AU - Sally, Mitchell

AU - Louis, Scott

AU - Friedman, Melissa

AU - Petersen, Floyd

AU - Malinoski, Darren

PY - 2017

Y1 - 2017

N2 - Background: There is a national shortage of organs available for transplantation, and utilization rates for thoracic organs are less than 40%. In addition, the optimal method of assessing cardiovascular status during donor management is uncertain. FloTrac is a noninvasive hemodynamic technique that measures cardiac output and fluid responsiveness. Our objective was to measure the impact of using this technique to guide management on fluid balance, vasopressor usage, thyroid hormone usage, and pulmonary function. We hypothesized that FloTrac guidance will increase thoracic organs transplanted per donor (OTPD). Methods: Data were prospectively collected on a convenience sample of 38 donors after neurologic determination of death. Organs transplanted, net fluid balance, dosage of vasopressors, dosage of thyroid hormone, and PaO2:FIO2 were compared between treatment and control groups. Results: The treatment group had greater thoracic OTPD (1.3 [1.0] vs 0.4 [0.6], P = .004) and overall OTPD (4.3 [1.5] vs 2.7 [1.5], P = .002). Donors in the treatment group maintained a neutral fluid balance, had more thyroid hormone used, and had an improvement in oxygenation. Conclusion: The implementation of this technology to aid providers may help ameliorate the shortage of thoracic and overall organs available for transplantation.

AB - Background: There is a national shortage of organs available for transplantation, and utilization rates for thoracic organs are less than 40%. In addition, the optimal method of assessing cardiovascular status during donor management is uncertain. FloTrac is a noninvasive hemodynamic technique that measures cardiac output and fluid responsiveness. Our objective was to measure the impact of using this technique to guide management on fluid balance, vasopressor usage, thyroid hormone usage, and pulmonary function. We hypothesized that FloTrac guidance will increase thoracic organs transplanted per donor (OTPD). Methods: Data were prospectively collected on a convenience sample of 38 donors after neurologic determination of death. Organs transplanted, net fluid balance, dosage of vasopressors, dosage of thyroid hormone, and PaO2:FIO2 were compared between treatment and control groups. Results: The treatment group had greater thoracic OTPD (1.3 [1.0] vs 0.4 [0.6], P = .004) and overall OTPD (4.3 [1.5] vs 2.7 [1.5], P = .002). Donors in the treatment group maintained a neutral fluid balance, had more thyroid hormone used, and had an improvement in oxygenation. Conclusion: The implementation of this technology to aid providers may help ameliorate the shortage of thoracic and overall organs available for transplantation.

KW - Donor management

KW - Stroke volume variation

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85020673974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020673974&partnerID=8YFLogxK

U2 - 10.1177/1526924817699966

DO - 10.1177/1526924817699966

M3 - Article

C2 - 28617162

AN - SCOPUS:85020673974

VL - 27

SP - 200

EP - 206

JO - Progress in Transplantation

JF - Progress in Transplantation

SN - 1526-9248

IS - 2

ER -